NCT01695915

Brief Summary

The purpose of the study is to determine the diurnal variation of rectal diameter in healthy and constipated children using transabdominal ultrasound.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2012

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2012

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

September 27, 2012

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 28, 2012

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2012

Completed
Last Updated

November 16, 2012

Status Verified

November 1, 2012

Enrollment Period

1 month

First QC Date

September 27, 2012

Last Update Submit

November 15, 2012

Conditions

Keywords

constipationchildrenhealthyrectal diameter

Outcome Measures

Primary Outcomes (1)

  • Rectal diameter

    24 hours

Study Arms (2)

Healthy

Transabdominal ultrasound

Procedure: Transabdominal ultrasound

Constipated

Transabdominal ultrasound

Procedure: Transabdominal ultrasound

Interventions

Transabdominal ultrasound are applied to the subjects every third hour during the study and every hour for three hours after a bowel movement.

ConstipatedHealthy

Eligibility Criteria

Age4 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Constipated children are recruited from the outpatient clinic at Kolding pediatric department. A list of patients which have been given the diagnose constipation are drawn from the computer and reviewed. Children between 4-12 years who fulfill the Rome III criteria of constipation and have been taking PEG maintenance treatment at least 1 month, are contacted by telephone for possible participation in the study. Healthy participants without constipation or other diseases affecting the gastrointestinal tract were recruited among the employees of the Department of Pediatrics at Kolding Hospital. Written informed consent was obtained from both parents before any procedures were initiated.

You may not qualify if:

  • Children with known organic causes of constipation, including Hirschsprungs disease, spinal and anal congenital abnormalities, previous surgery on the colon, inflammatory bowel disease, allergy and metabolic or endocrine diseases.
  • Children receiving drugs known to affect bowel function during a 2 month period before initiation besides laxatives.
  • Children between 4 and 12 years of age.
  • Children with known organic causes of constipation, including Hirschsprungs disease, spinal and anal congenital abnormalities, previous surgery on the colon, inflammatory bowel disease, allergy and metabolic or endocrine diseases.
  • Children receiving drugs known to affect bowel function during a 2 month period before initiation.
  • Children with a previous history of constipation, fecal incontinence and / or urinary tract infections.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pediatric department, Kolding Hospital

Kolding, 6000, Denmark

Location

MeSH Terms

Conditions

Constipation

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Line Modin, MD

    Kolding Sygehus

    PRINCIPAL INVESTIGATOR
  • Marianne Jakobsen, MD, phd

    Kolding Sygehus

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Medical doctor

Study Record Dates

First Submitted

September 27, 2012

First Posted

September 28, 2012

Study Start

September 1, 2012

Primary Completion

October 1, 2012

Study Completion

October 1, 2012

Last Updated

November 16, 2012

Record last verified: 2012-11

Locations